Sponsor Pipeline

Werewolf Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06939283 A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With… Advanced or Metastatic Solid Tumors Active, Not Recruiting
Phase 1
NCT05479812 Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With… Metastatic Solid Tumor Active, Not Recruiting
Disease Areas
Non-Hodgkin Lymphoma (1)
Get alerts when Werewolf Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free